CIRESI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 7.915
EU - Europa 6.654
AS - Asia 1.715
AF - Africa 448
SA - Sud America 183
OC - Oceania 115
Continente sconosciuto - Info sul continente non disponibili 23
Totale 17.053
Nazione #
US - Stati Uniti d'America 7.658
IT - Italia 2.524
FR - Francia 1.379
DE - Germania 898
CN - Cina 676
PL - Polonia 516
GB - Regno Unito 311
IN - India 298
NG - Nigeria 257
UA - Ucraina 195
CA - Canada 184
RU - Federazione Russa 108
AU - Australia 104
TR - Turchia 101
BR - Brasile 96
ID - Indonesia 88
JP - Giappone 80
NL - Olanda 77
IQ - Iraq 75
ZA - Sudafrica 71
CZ - Repubblica Ceca 69
RO - Romania 69
IE - Irlanda 66
IR - Iran 59
EG - Egitto 58
SE - Svezia 54
ES - Italia 48
KR - Corea 47
FI - Finlandia 40
MX - Messico 39
HK - Hong Kong 38
TW - Taiwan 37
GR - Grecia 34
CL - Cile 32
PH - Filippine 32
CH - Svizzera 29
PK - Pakistan 28
BE - Belgio 27
LT - Lituania 26
DK - Danimarca 25
BG - Bulgaria 23
CO - Colombia 20
EU - Europa 19
AT - Austria 17
HN - Honduras 17
SG - Singapore 17
AE - Emirati Arabi Uniti 16
MY - Malesia 16
SA - Arabia Saudita 16
NO - Norvegia 15
PT - Portogallo 15
TH - Thailandia 15
VN - Vietnam 15
DZ - Algeria 14
AR - Argentina 13
MK - Macedonia 13
RS - Serbia 12
SD - Sudan 12
IL - Israele 11
LV - Lettonia 10
NZ - Nuova Zelanda 10
PE - Perù 10
SK - Slovacchia (Repubblica Slovacca) 10
GH - Ghana 8
SI - Slovenia 8
EC - Ecuador 7
KW - Kuwait 6
KZ - Kazakistan 6
SC - Seychelles 6
BA - Bosnia-Erzegovina 5
ET - Etiopia 5
HR - Croazia 5
HU - Ungheria 5
JO - Giordania 5
TN - Tunisia 5
AL - Albania 4
CY - Cipro 4
GY - Guiana 4
ME - Montenegro 4
MM - Myanmar 4
QA - Qatar 4
BD - Bangladesh 3
BZ - Belize 3
CU - Cuba 3
MT - Malta 3
NA - Namibia 3
PR - Porto Rico 3
UZ - Uzbekistan 3
AP - ???statistics.table.value.countryCode.AP??? 2
BY - Bielorussia 2
CR - Costa Rica 2
GE - Georgia 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
NP - Nepal 2
Totale 17.029
Città #
Fairfield 1.020
Houston 820
Ashburn 549
Woodbridge 497
Seattle 446
Ann Arbor 428
Buffalo 364
Des Moines 331
Cambridge 330
Wilmington 321
Santa Cruz 316
Palermo 243
Beijing 173
Rome 158
Milan 148
Wuhan 97
Nürnberg 84
Mountain View 77
San Diego 64
Las Vegas 56
Toronto 56
Chicago 55
Phoenix 52
Boardman 50
Bengaluru 49
Dublin 49
Muizenberg 49
Ottawa 49
Clearwater 44
Los Angeles 44
Guangzhou 42
Shanghai 42
São Paulo 42
University Park 40
Jakarta 36
Leawood 36
Napoli 35
Naples 33
Henderson 32
Paris 32
Hangzhou 30
Helsinki 29
Ankara 27
Dallas 27
New York 27
Florence 26
Catania 25
Taipei 25
Bari 24
Riva 24
Turin 24
Genoa 23
Istanbul 23
Nanjing 22
San Jose 22
Old Bridge 21
Oldenburg 21
San Francisco 21
Dearborn 20
Brooklyn 19
Coimbatore 19
Hilla 19
Shenyang 19
Council Bluffs 18
Hyderabad 18
Jinan 18
Milpitas 18
Bologna 17
Brescia 17
Scranton 17
Verona 17
Erice 16
Islamabad 16
London 16
Chengdu 15
Frankfurt Am Main 15
Polska 15
Provo 14
Seoul 14
Amsterdam 13
Athens 13
Boulder 13
Grenoble 13
Lake Forest 13
Medellín 13
Norwalk 13
Stockholm 13
Torino 13
Bad Vilbel 12
Cairo 12
Izmir 12
Padova 12
San Giuliano Milanese 12
San Mateo 12
Sydney 12
Bangalore 11
Bergamo 11
Centro 11
Madrid 11
Monza 11
Totale 8.443
Nome #
EFFECT OF SWITCH FROM CONVENTIONAL GLUCOCORTICOIDS TO “DUAL RELEASE HYDROCORTISONE” (DR-HC) ON METABOLIC PROFILE AND QUALITY OF LIFE IN ADULT PATIENTS WITH SECONDARY ADRENAL INSUFFICIENCY (SAI): RESULTS OF THREE MONTHS FOLLOW-UP, file e3ad8916-cc19-da0e-e053-3705fe0a2b96 1.290
Commento a "Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children ", file e3ad891b-6974-da0e-e053-3705fe0a2b96 946
LONG-TERM METABOLIC EFFECTS OF GH THERAPY IN CHILDREN WITH IDIOPATHIC GH DEFICIENCY, file e3ad8916-9847-da0e-e053-3705fe0a2b96 748
Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance., file e3ad891b-cf24-da0e-e053-3705fe0a2b96 583
The relationship between metabolic syndrome and bone health: results of a retrospective gender specific female study., file e3ad8916-9a45-da0e-e053-3705fe0a2b96 576
Commento a "The impact of real practice inappropriateness and devices' inefficiency to variability in growth hormone consumption", file e3ad891b-820d-da0e-e053-3705fe0a2b96 528
Vitamin D across growth hormone (GH) disorders: From GH deficiency to GH excess, file e3ad891a-eae9-da0e-e053-3705fe0a2b96 527
Early Lung Function Abnormalities in Acromegaly., file e3ad8917-a777-da0e-e053-3705fe0a2b96 508
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels., file e3ad8916-60a7-da0e-e053-3705fe0a2b96 406
EFFECTS OF PASIREOTIDE TREATMENT ON CARDIOMETABOLIC RISK IN PATIENTS WITH CUSHING’S DISEASE : AN ITALIAN, MULTICENTER STUDY, file e3ad891b-7700-da0e-e053-3705fe0a2b96 398
Corneal thickness in children with growth hormone deficiency: The effect of GH treatment., file e3ad8916-bf29-da0e-e053-3705fe0a2b96 368
Utility of C-peptide for a reliable estimate of insulin secretion in children with growth hormone deficiency., file e3ad8919-a015-da0e-e053-3705fe0a2b96 367
Growth hormone and hematopoiesis: A retrospective analysis on a large cohort of children with growth hormone deficiency, file e3ad891d-9b71-da0e-e053-3705fe0a2b96 353
Insulin sensitivity and secretion and adipokine profile in patients with Cushing’s disease treated with pasireotide, file e3ad891d-ba6b-da0e-e053-3705fe0a2b96 335
The visceral adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency, file e3ad891a-a7b7-da0e-e053-3705fe0a2b96 334
Prevalence and clinical features of polycystic ovarian syndrome in adolescents with previous childhood growth hormone deficiency., file e3ad8919-9ad9-da0e-e053-3705fe0a2b96 329
Correlation between adrenal function, growth hormone secretion, and insulin sensitivity in children with idiopathic growth hormone deficiency, file e3ad891b-4948-da0e-e053-3705fe0a2b96 322
GHD come predittore di sindrome metabolica, file e3ad891a-fdc9-da0e-e053-3705fe0a2b96 321
Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children, file e3ad8919-32cd-da0e-e053-3705fe0a2b96 307
Comparison between euglycemic hyperinsulinemic clamp and surrogate indices of insulin sensitivity in children with growth hormone deficiency, file e3ad891c-9413-da0e-e053-3705fe0a2b96 304
Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study, file e3ad891b-9fa6-da0e-e053-3705fe0a2b96 294
Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory, file e3ad891b-f1db-da0e-e053-3705fe0a2b96 294
The lacrimal gland herniation role in the Graves’ orbitopathy, file e3ad891b-3dfd-da0e-e053-3705fe0a2b96 292
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual association?, file e3ad8918-0fcf-da0e-e053-3705fe0a2b96 285
OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes., file e3ad8915-d5f9-da0e-e053-3705fe0a2b96 269
Improved insulin sensitivity and secretion in prediabetic patients with adrenal insufficiency on dual-release hydrocortisone treatment: a 36-month retrospective analysis, file e3ad891d-1095-da0e-e053-3705fe0a2b96 268
Revaluation of the clinical and metabolic behavior of children with isolated growth hormone deficiency during GH treatment according to newly proposed note 39 of the Italian Medicines Agency (AIFA)., file e3ad8918-2daf-da0e-e053-3705fe0a2b96 265
Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations, file e3ad8918-1ffd-da0e-e053-3705fe0a2b96 260
Circulating adipokine levels in diabetic patients with Cushing disease on pasireotide treatment compared with patients with type 2 diabetes mellitus, file e3ad891b-6f72-da0e-e053-3705fe0a2b96 246
Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?, file e3ad8916-b0d0-da0e-e053-3705fe0a2b96 240
Reduction in insulin sensitivity and inadequate β-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth hormone deficiency during 12 months of growth hormone treatment, file e3ad8918-08c8-da0e-e053-3705fe0a2b96 222
Identification of Novel Wsf1 Mutations in a Sicilian Child with Wolfram Syndrome, file e3ad8917-ccfa-da0e-e053-3705fe0a2b96 210
Complete biochemical control and pituitary adenoma disappearance in a child with gigantism: efficacy of octreotide therapy, file e3ad8916-b313-da0e-e053-3705fe0a2b96 198
The Daily Consumption of Cola Can Determine Hypocalcemia: A Case Report of Postsurgical Hypoparathyroidism-Related Hypocalcemia Refractory to Supplemental Therapy with High Doses of Oral Calcium, file e3ad891a-91cd-da0e-e053-3705fe0a2b96 194
Relative Hypoleptinemia in poor controlled patients with Type 1 Diabetes, file e3ad8918-03b4-da0e-e053-3705fe0a2b96 180
Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study., file e3ad891b-5e2d-da0e-e053-3705fe0a2b96 173
Visceral Adiposity Index Is Associated with Insulin Sensitivity and Adipocytokine Levels in Newly Diagnosed Acromegalic Patients., file e3ad8917-8abd-da0e-e053-3705fe0a2b96 165
Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS, file e3ad891b-9c02-da0e-e053-3705fe0a2b96 165
Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: A retrospective analysis, file e3ad891d-1d6c-da0e-e053-3705fe0a2b96 163
Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report, file e3ad891d-2387-da0e-e053-3705fe0a2b96 162
Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment., file e3ad891c-e37e-da0e-e053-3705fe0a2b96 149
The metabolic outcomes of growth hormone treatment in children are gender specific, file e3ad891d-06d3-da0e-e053-3705fe0a2b96 148
Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency, file e3ad8918-0fd0-da0e-e053-3705fe0a2b96 141
Improved cardiovascular and cardiometabolic risk in patients with type 1 diabetes and autoimmune polyglandular syndrome switched from glargine to degludec due to hypoglycaemic variability, file e3ad891d-83e9-da0e-e053-3705fe0a2b96 137
The adipose visceral dysfunction plays an important role in diabetes in Cushing disease., file e3ad8916-99fa-da0e-e053-3705fe0a2b96 136
Glucose metabolism in children with growth hormone deficiency, file e3ad891c-ef84-da0e-e053-3705fe0a2b96 124
Alterazioni del metabolismo glucidico determinate da eccesso di ormoni controregolatori: ruolo del GH, file e3ad8916-b6b1-da0e-e053-3705fe0a2b96 118
Valutazione del C-peptide come migliore indice di insulino-secrezione in bambini affetti da deficit di GH, file e3ad891b-2c9e-da0e-e053-3705fe0a2b96 116
Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency, file e3ad891f-9e17-da0e-e053-3705fe0a2b96 116
Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients., file e3ad8916-b527-da0e-e053-3705fe0a2b96 111
The Metabolic Profile in Active Acromegaly is Gender-Specific., file e3ad8916-5a74-da0e-e053-3705fe0a2b96 110
Erratum to: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study (Diabetes Therapy, (2018), 9, 1, (363-371), 10.1007/s13300-017-0338-4), file e3ad8921-5a4a-da0e-e053-3705fe0a2b96 108
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome, file e3ad891b-03ff-da0e-e053-3705fe0a2b96 104
Hepatic steatosis index in acromegaly: Correlation with insulin resistance regardless of the disease control, file e3ad8922-2858-da0e-e053-3705fe0a2b96 100
Glycometabolic control in Acromegalic patients with Diabetes: a study of the effects of different treatments for GH excess and for hyperglycaemia., file e3ad891b-c37c-da0e-e053-3705fe0a2b96 96
More favorable metabolic impact of three-times-weekly versus daily growth hormone (GH) treatment in naïve GH-deficient children, file e3ad891b-6e99-da0e-e053-3705fe0a2b96 94
Circulating Irisin Levels in Children with GH Deficiency before and after 1 Year of GH Treatment, file e3ad891e-d726-da0e-e053-3705fe0a2b96 80
Studio randomizzato controllato, della durata di 2 anni, sugli effetti e la sicurezza di differenti dosaggi di r-hGH, titolati sulla base dei livelli di IGF1 in pazienti con bassa statura in trattamento: considerazioni terapeutiche e farmacoeconomiche, file e3ad891b-314d-da0e-e053-3705fe0a2b96 79
Diversa efficacia clinica e biochimica della terapia con liraglutide in una popolazione di diabetici di tipo 2 in relazione ai valori basali di HbA1c, file e3ad891b-245a-da0e-e053-3705fe0a2b96 70
Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index, file e3ad8917-e561-da0e-e053-3705fe0a2b96 68
Valutazione dell’insulino-sensibilità e della funzione adiposa viscerale nel diabete mellito tipo 1 autoimmune ed idiopatico., file e3ad8916-b8dd-da0e-e053-3705fe0a2b96 67
Miglioramento dell'insulino-sensibilità e dell'insulino-secrezione dopo switch da terapia con glucocorticoidi tradizionali a idrocortisone "dual release" in pazienti affetti da iposurrenalismo, file e3ad891b-5e95-da0e-e053-3705fe0a2b96 66
Clinical and metabolic impact of three-times-weekly versus daily growth hormone (GH) treatment in naïve GH-deficient children, file e3ad891b-5eb1-da0e-e053-3705fe0a2b96 66
Impact of obesity, insulin resistance and hyperandrogenism on steatosis and fibrosis risk in young females with PCOS, file e3ad891b-7ea4-da0e-e053-3705fe0a2b96 66
Rivalutazione delle caratteristiche cliniche e metaboliche di bambini con deficit isolato di ormone della crescita durante il trattamento con GH secondo la modifica alla nota 39 AIFA, file e3ad891b-3ece-da0e-e053-3705fe0a2b96 64
Clamp euglicemico iperinsulinemico e test al glucagone come utili strumenti di valutazione degli effetti metabolici della terapia sostitutiva con GH., file e3ad8916-b86a-da0e-e053-3705fe0a2b96 58
Valutazione dell’insulino-sensibilità tramite clamp euglicemico iperinsulinemico in bambini in terapia sostitutiva con GH., file e3ad891c-f0b6-da0e-e053-3705fe0a2b96 54
Visceral Adipose function, insulin sensitivity and secretion in active acromegaly., file e3ad8915-fa24-da0e-e053-3705fe0a2b96 49
L’insulino-resistenza è il principale fattore indipendente correlato con l’aumentato rischio metabolico nelle donne affette da PCOS, file e3ad891d-4c87-da0e-e053-3705fe0a2b96 49
IPOVITAMINOSI D ED EFFETTI BENEFICI DELLA TERAPIA SOSTITUTIVA CON GH SUI LIVELLI DI VITAMINA D IN BAMBINI AFFETTI DA DEFICIT DI GH, file e3ad8916-fb91-da0e-e053-3705fe0a2b96 45
IL CONSUMO DI BEVANDE RICCHE DI ACIDO ORTOFOSFORICO COME FATTORE DI RISCHIO PER LO SVILUPPO DI IPOCALCEMIA: IL CASO DI UNA DONNA CON IPOPARATIROIDISMO POST-CHIRURGICO, file e3ad8916-f788-da0e-e053-3705fe0a2b96 36
Diabete e complicanze materno-fetali in gravidanza: confronto tra pazienti con diabete tipo 1 e tipo 2 pregravidico., file e3ad891d-4c8b-da0e-e053-3705fe0a2b96 35
Maggiore rischio cardiometabolico in pazienti di razza non caucasica affetti da diabete mellito di tipo 1 idiopatico rispetto alla forma autoimmune in pazienti caucasici., file e3ad891d-4c89-da0e-e053-3705fe0a2b96 34
Thyroid function during long-term GH treatment in children affected by idiopathic GH deficiency, file e3ad8916-b71b-da0e-e053-3705fe0a2b96 32
Poor diagnostic value of the euglycemic-hyperinsulinemic clamp in the clinical assessment of insulin resistant women with PCOS., file e3ad8916-99fd-da0e-e053-3705fe0a2b96 27
Correlation between Severity of Growth Hormone Deficiency and Thyroid Metabolism and Effects of Long-Term Growth Hormone Treatment on Thyroid Function in Children with Idiopathic Growth Hormone Deficiency., file e3ad8916-bf27-da0e-e053-3705fe0a2b96 26
LA TERAPIA CON GH PEGGIORA L'INSULINO-SENSIBILITA' SENZA UN'ADEGUATA RISPOSTA PANCREATICA COMPENSATORIA IN BAMBINI AFFETTI DA DEFICIT DI GH DURANTE IL PRIMO ANNO DI TERAPIA, file e3ad8916-f654-da0e-e053-3705fe0a2b96 26
Trattamento con GH e metabolismo glucidico, file e3ad891b-1bd9-da0e-e053-3705fe0a2b96 25
Alte dosi di cabergolina migliorano i parametri metabolici in pazienti affetti da prolattinoma., file e3ad8916-6034-da0e-e053-3705fe0a2b96 23
High prevalence of hypovitaminosis D in Sicilian children affected by growth hormone deficiency and its improvement after 12 months of replacement treatment., file e3ad8916-fafd-da0e-e053-3705fe0a2b96 23
Lacrimal glands herniation in patients with Graves’ Ophthalmopathy: an effective MRI-derived marker of disease activity, file e3ad891e-3b4f-da0e-e053-3705fe0a2b96 23
Decreased regulatory CD4+CD25+ Treg cells in newly diagnosed type 1 diabetes, file e3ad8916-b526-da0e-e053-3705fe0a2b96 21
Miglioramento clinico e metabolico in pazienti affetti da diabete mellito tipo 1 associato ad altre endocrinopatie (APS) dopo shift della terapia insulinica basale con glargine a degludec, file e3ad891c-f4ad-da0e-e053-3705fe0a2b96 21
Maggior rischio cardiometabolico nelle donne affette da Cushing, anche in assenza di una franca Sindrome Metabolica., file e3ad8916-6038-da0e-e053-3705fe0a2b96 19
Pasireotide versus pituitary surgery: a retrospective analysis of 12 months of treatment in patients with Cushing's disease, file e3ad891b-4944-da0e-e053-3705fe0a2b96 19
Cornea in acromegalic patients as a possible target of growth hormone action., file e3ad891d-458f-da0e-e053-3705fe0a2b96 17
No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus., file e3ad8916-b0a6-da0e-e053-3705fe0a2b96 16
Modificazioni di insulino-secrezione, insulino-sensibilità e funzione adiposa durante terapia con pasireotide in un gruppo di pazienti con malattia di Cushing, file e3ad891b-494d-da0e-e053-3705fe0a2b96 16
Comparison of clinical and metabolic effects of pasireotide and pituitary surgery in Cushing disease, file e3ad891b-4b54-da0e-e053-3705fe0a2b96 14
La transizione del soggetto cronicamente malato dall’età pediatrica all’età adulta, file e3ad8916-b31c-da0e-e053-3705fe0a2b96 12
Effect of the switch from conventional to “dual release hydrocortisone” in adult patients with primary and secondary adrenal insufficiency: a six-months multicenter study, file e3ad8917-d758-da0e-e053-3705fe0a2b96 12
null, file e3ad8916-fab7-da0e-e053-3705fe0a2b96 11
EFFETTI METABOLICI DELLA TERAPIA SOSTITUTIVA CON GH IN BAMBINI AFFETTI DA DEFICIT DI GH DURANTE UN FOLLOW-UP DI 36 MESI, file e3ad8916-fce5-da0e-e053-3705fe0a2b96 11
Effect of the switch from conventional to “dual release hydrocortisone” in adult patients with primary and secondary adrenal insufficiency: a six-months multicenter study, file e3ad8917-d757-da0e-e053-3705fe0a2b96 10
Lacrimal gland herniation in Graves ophthalmopathy: a simple and useful MRI biomarker of disease activity, file 55ae3545-1c89-4925-b883-54a135e6604c 9
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia, severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations in acromegaly due to a therapeutically resistant pituitary GH-secreting macroadenoma, file e3ad8916-cfaf-da0e-e053-3705fe0a2b96 7
Revaluation of the clinical and metabolic behavior of GHD children during GH treatment according to newly proposed note 39 of the Italian Medicines Agency (AIFA), file e3ad8917-d668-da0e-e053-3705fe0a2b96 6
Lacrimal gland herniation in Graves ophthalmopathy: a simple and useful MRI biomarker of disease activity, file e3ad8921-0691-da0e-e053-3705fe0a2b96 5
Visfatin as a marker of adipose dysfunction and metabolic impairment in active acromegaly and its possible use during the follow-up, file e3ad8917-d75f-da0e-e053-3705fe0a2b96 4
INSULIN SECRETION AND SENSITIVITY DURING PASIREOTIDE TREATMENT IN PATIENTS WITH RECURRENT CUSHING DISEASE: A CASE SERIES, file e3ad8917-eb7c-da0e-e053-3705fe0a2b96 4
Totale 17.728
Categoria #
all - tutte 31.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.087 0 0 0 0 0 0 0 0 0 332 404 351
2019/20203.804 287 282 301 620 388 280 268 538 282 190 205 163
2020/20212.405 171 189 236 176 202 197 224 189 210 219 227 165
2021/20222.913 248 231 257 526 408 105 144 159 120 121 404 190
2022/20232.070 81 148 342 217 181 165 434 76 88 78 178 82
2023/20242.555 66 113 171 166 202 125 381 1.140 89 102 0 0
Totale 17.743